by Sabine Possmann | Jan 7, 2020 | Uncategorized
With the first approvals of the CAR T cell treatments in Europe, a partial victory in the fight against hematological malignancies was achieved. However, the route from bench to bedside poses several challenges, demanding for a European-wide harmonization process....
